CA2484940A1 - Procedes et compositions permettant de modifier des acides nucleiques - Google Patents

Procedes et compositions permettant de modifier des acides nucleiques Download PDF

Info

Publication number
CA2484940A1
CA2484940A1 CA002484940A CA2484940A CA2484940A1 CA 2484940 A1 CA2484940 A1 CA 2484940A1 CA 002484940 A CA002484940 A CA 002484940A CA 2484940 A CA2484940 A CA 2484940A CA 2484940 A1 CA2484940 A1 CA 2484940A1
Authority
CA
Canada
Prior art keywords
biological composition
compound
nucleic acid
acid molecules
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002484940A
Other languages
English (en)
Inventor
Kevin Plunkett
Andrei A. Purmal
Boris Zavizion
John Chapman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
VI Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VI Technologies Inc filed Critical VI Technologies Inc
Publication of CA2484940A1 publication Critical patent/CA2484940A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14361—Methods of inactivation or attenuation
    • C12N2750/14363—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des procédés et des compositions permettant de modifier des acides nucléiques.
CA002484940A 2002-05-06 2003-05-06 Procedes et compositions permettant de modifier des acides nucleiques Abandoned CA2484940A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37818402P 2002-05-06 2002-05-06
US60/378,184 2002-05-06
PCT/US2003/014363 WO2003093512A1 (fr) 2002-05-06 2003-05-06 Procedes et compositions permettant de modifier des acides nucleiques

Publications (1)

Publication Number Publication Date
CA2484940A1 true CA2484940A1 (fr) 2003-11-13

Family

ID=29401590

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002484940A Abandoned CA2484940A1 (fr) 2002-05-06 2003-05-06 Procedes et compositions permettant de modifier des acides nucleiques

Country Status (5)

Country Link
EP (1) EP1549761A4 (fr)
JP (1) JP2005524707A (fr)
AU (1) AU2003228919A1 (fr)
CA (1) CA2484940A1 (fr)
WO (1) WO2003093512A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
CA3107314A1 (fr) * 2018-07-27 2020-01-30 Zata Pharmaceuticals, Inc. Procede d'inactivation de pathogenes, de microorganismes et de parasites
CN112342144B (zh) * 2020-09-28 2023-02-14 江西农业大学 一株百岁兰曲霉菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6352695B1 (en) * 1997-10-03 2002-03-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
WO2000044720A1 (fr) * 1999-01-29 2000-08-03 V.I. Technologies, Inc. Synthese d'ethyleneimine dimere

Also Published As

Publication number Publication date
AU2003228919A1 (en) 2003-11-17
EP1549761A4 (fr) 2006-02-15
EP1549761A1 (fr) 2005-07-06
WO2003093512A1 (fr) 2003-11-13
JP2005524707A (ja) 2005-08-18

Similar Documents

Publication Publication Date Title
KR100486765B1 (ko) 핵산의 선택적 변형방법 및 조성물
JP5244083B2 (ja) 病原体不活化のための脆い化合物
AU750540B2 (en) Methods and compositions for the selective modification of nucleic acids
US6617157B1 (en) Methods and compositions for the selective modification of nucleic acids
Rosenberg Some biological effects of platinum compounds
JP2945360B2 (ja) 抗腫瘍性、抗ウイルス性、抗レトロウイルス性および殺虫性スペルミン誘導体
JP4643004B2 (ja) 生体材料中の病原体不活性化剤をクエンチするための方法
US6774123B1 (en) Methods and compositions for inactivating viruses
CN1347323A (zh) 化合物
CA2484940A1 (fr) Procedes et compositions permettant de modifier des acides nucleiques
EP3710007A1 (fr) Utilisation d'imidazopyrimidine pour moduler une réponse immunitaire humaine
US6352695B1 (en) Methods and compositions for the selective modification of nucleic acids
US5663043A (en) Method for inactivating non-enveloped viruses using a viricide-potentiating agent with a photoactivatible virucide
US20040053208A1 (en) Methods to selectively inactivate parasites in biological compositions
WO2000018969A1 (fr) Procede selectif d'inactivation de virus dans des compositions biologiques
US20020034724A1 (en) Methods to selectively inactivate microorganisms in biological compositions
RU2049477C1 (ru) Способ изготовления инактивированной вакцины против классической чумы свиней
US20040048235A1 (en) Methods and compositions for the selective modification of nucleic acids
US20030103996A1 (en) Cell-based vaccine
JPH02174724A (ja) 抗エイズウイルス剤

Legal Events

Date Code Title Description
FZDE Dead